CEO: Andrew R. Allen

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.


Key numbers

Market Capitalization:126701000
Shares Outstanding: 37265000
Float: 22384266
Next Earning Date:2020-08-17
TTm EPS: -2.886
TTm Dividend Rate:
200 days moving average:7.48
50 days moving average: 5.88
One day percent Change: -3.31



2017-12-31, 2018-06-30, 2018-09-30, 2018-12-31,
2017-12-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,